Amy Chieng

Stanford University

Papers

1

Total Citations

6

H-Index

1

About

Dr. Amy Chieng is a pioneering researcher at the intersection of digital therapeutics and behavioral health, with a primary focus on leveraging conversational agents to address substance use disorders. Her most notable contribution is the development and rigorous testing of Woebot, a relational agent designed to deliver scalable, evidence-based interventions for adults struggling with substance use. In her landmark 2023 protocol paper, which has already garnered 6 citations, Dr. Chieng outlines a randomized controlled trial comparing Woebot against a psychoeducational comparator—a study that promises to establish digital therapeutics as a viable, population-level strategy for treating substance use disorders. Building on two formative studies that demonstrated Woebot’s feasibility and acceptability, her work directly confronts the pressing need for accessible, non-stigmatizing care in a field where traditional treatment options are often limited. Dr. Chieng’s research is distinguished by its methodological rigor and its potential to democratize access to mental health support, making her a leading voice in the emerging field of AI-driven behavioral interventions.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
A relational agent for treating substance use in adults: Protocol for a randomized controlled trial with a psychoeducational comparator
6 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Stanford University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago